Item 9 Labs Corp (INLB)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 07, 13:40
Item 9 Labs Profit Margin (Quarterly): -117.7% for June 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -117.7% |
| March 31, 2023 | -60.33% |
| December 31, 2022 | -65.10% |
| September 30, 2022 | -461.1% |
| June 30, 2022 | -110.9% |
| March 31, 2022 | -58.42% |
| December 31, 2021 | -54.07% |
| September 30, 2021 | -148.4% |
| June 30, 2021 | -12.46% |
| March 31, 2021 | 0.80% |
| December 31, 2020 | -35.35% |
| September 30, 2020 | -283.4% |
| June 30, 2020 | -72.84% |
| March 31, 2020 | -84.64% |
| December 31, 2019 | -127.2% |
| September 30, 2019 | -594.3% |
| June 30, 2019 | -55.16% |
| March 31, 2019 | -78.19% |
| December 31, 2018 | -34.41% |
| September 30, 2018 | -82.29% |
| June 30, 2018 | -78.47% |
| March 31, 2018 | -9.81% |
| December 31, 2017 | -978.9% |
| September 30, 2017 | -114.2% |
| June 30, 2017 | -8.79% |
| Date | Value |
|---|---|
| March 31, 2017 | -226.4% |
| December 31, 2016 | -879.7% |
| September 30, 2016 | -490.1% |
| June 30, 2016 | -629.7% |
| March 31, 2016 | -12.57K% |
| December 31, 2015 | -377.5% |
| September 30, 2015 | |
| June 30, 2015 | -5.97K% |
| March 31, 2015 | -9.52K% |
| December 31, 2014 | -989.6% |
| September 30, 2014 | -6.49K% |
| June 30, 2014 | -581.9% |
| March 31, 2014 | -32.61K% |
| December 31, 2013 | -10.92K% |
| September 30, 2013 | -1.24K% |
| June 30, 2013 | -106.9K% |
| March 31, 2013 | -373.8% |
| December 31, 2012 | -485.7% |
| June 30, 2012 | -60.97K% |
| March 31, 2012 | -16.46K% |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | -1.43K% |
| March 31, 2011 | -2.23K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-594.3%
Minimum
Sep 2019
0.80%
Maximum
Mar 2021
-137.7%
Average
-72.84%
Median
Jun 2020
Profit Margin (Quarterly) Benchmarks
| Humanigen Inc | -1.89K% |
| Cantabio Pharmaceuticals Inc | -- |
| Affymax Inc | -- |
| RVL Pharmaceuticals PLC | -289.3% |
| Scopus BioPharma Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.87% |
| Return on Assets | -27.12% |
| Return on Invested Capital | -33.30% |
| Gross Profit Margin (Quarterly) | 56.13% |
| Operating Margin (Quarterly) | -55.70% |
| Return on Net Operating Assets | -31.24% |